北京大学学报(医学版) ›› 2026, Vol. 58 ›› Issue (3): 674-677. doi: 10.19723/j.issn.1671-167X.2026.03.031

• 短篇论著 • 上一篇    

B/C基因型的乙型肝炎病毒在不同丙氨酸氨基转移酶状态下对Th17、Treg细胞及其比率的影响

高鹏1, 刘燕玲1, 李俊峰2, 姚立琼1,*()   

  1. 1 兰州大学第一医院医学检验中心,兰州 730000
    2 兰州大学第一医院传染科,兰州 730000
  • 收稿日期:2024-07-05 出版日期:2026-06-18 发布日期:2026-04-23
  • 通讯作者: 姚立琼
  • 基金资助:
    国家自然科学基金(81800528)

高鹏1, 刘燕玲1, 李俊峰2, 姚立琼1,*()   

  • Received:2024-07-05 Online:2026-06-18 Published:2026-04-23
  • Contact: 姚立琼
  • Supported by:
    the National Science Foundation of China(81800528)

RICH HTML

  

关键词: 乙肝, 基因型, 丙氨酸氨基转移酶, Th17细胞, Treg细胞

中图分类号: 

  • R512.62

表1

ALT正常组中不同基因型的乙型肝炎病毒对Th17、Treg细胞及其比率的影响"

Items B type C type t P
n 35 38
HBV DNA 5.097±1.116 5.279±1.299 -0.637 0.526
Th17/% 1.818±0.112 1.832±0.123 -0.491 0.625
Treg/% 4.865±0.196 4.918±0.168 -1.242 0.218
Th17/Treg 0.374±0.026 0.373±0.02 -0.206 0.837

表2

ALT高于正常上限且小于正常上限2倍组中,不同基因型的乙型肝炎病毒对Th17、Treg细胞及其比率的影响"

Items B type C type t P
n 37 35
HBV DNA 5.330±1.139 5.247±1.260 0.290 0.773
Th17/% 2.560±0.347 2.525±0.348 0.426 0.671
Treg/% 5.501±0.404 5.513±0.356 -0.134 0.893
Th17/Treg 0.468±0.073 0.461±0.074 0.435 0.665

表3

ALT≥2倍上限组中不同基因型的乙型肝炎病毒对Th17、Treg细胞及其比率的影响"

Items B type C type t P
n 38 37
HBV DNA 5.331±1.190 5.451±1.145 -0.445 0.658
Th17/% 3.970±0.537 4.718±0.591 -5.733 <0.001
Treg/% 5.967±0.320 6.543±0.416 -6.724 <0.001
Th17/Treg 0.667±0.095 0.724±0.102 -2.506 0.014
1
Zamor PJ , Lane AM . Interpretation of HBV serologies[J]. Clin Liver Dis, 2021, 25 (4): 689- 709.

doi: 10.1016/j.cld.2021.06.012
2
Pollicino T , Caminiti G . HBV-integration studies in the clinic: Role in the natural history of infection[J]. Viruses, 2021, 13 (3): 368.

doi: 10.3390/v13030368
3
Bello KE , Mat Jusoh TNA , Irekeola AA , et al. A recent prevalence of hepatitis B virus (HBV) genotypes and subtypes in Asia: A systematic review and meta-analysis[J]. Healthcare, 2023, 11 (7): 1011- 1018.

doi: 10.3390/healthcare11071011
4
Gu Y , Li X , Gu L , et al. An immuno-clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B[J]. Aging, 2020, 12 (24): 26063- 26079.

doi: 10.18632/aging.202274
5
Li K , Liu H , Guo T . Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients[J]. Clin Res Hepatol Gastroenterol, 2017, 41 (4): 399- 407.

doi: 10.1016/j.clinre.2016.12.004
6
Jose-Abrego A , Roman S , Laguna-Meraz S , et al. Host and HBV interactions and their potential impact on clinical outcomes[J]. Pathogens, 2023, 12 (9): 1146- 1152.

doi: 10.3390/pathogens12091146
7
Nicolini LA , Orsi A , Tatarelli P , et al. A global view to HBV chronic infection: Evolving strategies for diagnosis, treatment and prevention in immunocompetent individuals[J]. Int J Environ Res Public Health, 2019, 16 (18): 3307.

doi: 10.3390/ijerph16183307
8
Hogan S , Page A , Dixit S , et al. HBV prevalence in Sub-continental countries: A systematic review and meta-analysis[J]. PLoS One, 2023, 18 (12): e0295670.
9
Chen J , Li L , Yin Q , et al. A review of epidemiology and clinical relevance of hepatitis B virus genotypes and subgenotypes[J]. Clin Res Hepatol Gastroenterol, 2023, 47 (7): 102180.

doi: 10.1016/j.clinre.2023.102180
10
Wang L , Zeng X , Wang Z , et al. Recent advances in understanding T cell activation and exhaustion during HBV infection[J]. Virol Sin, 2023, 38 (6): 851- 859.

doi: 10.1016/j.virs.2023.10.007
11
Wan Z , Zhou Z , Liu Y , et al. Regulatory T cells and T helper 17 cells in viral infection[J]. Scand J Immunol, 2020, 91 (5): e12873.

doi: 10.1111/sji.12873
12
高鹏, 雒艳萍. 乙型肝炎病毒在不同丙氨酸氨基转移酶状态下对Th17、Treg细胞及其比率的影响[J]. 北京大学学报(医学版), 2022, 54 (2): 272- 277.

doi: 10.19723/j.issn.1671-167X.2022.02.012
13
Beňová K , Hancková M , Koći K , et al. T cells and their function in the immune response to viruses[J]. Acta Virol, 2020, 64 (2): 131- 143.

doi: 10.4149/av_2020_203
14
Cui D , Jiang D , Yan C , et al. Immune checkpoint molecules expressed on CD4+ T cell subsets in chronic asymptomatic hepatitis B virus carriers with hepatitis B e antigen-negative[J]. Front Microbiol, 2022, 13, 887408.

doi: 10.3389/fmicb.2022.887408
15
Xu J , Zhan Q , Fan Y , et al. Human genetic susceptibility to hepatitis B virus infection[J]. Infect Genet Evol, 2021, 87, 104663.
16
Revill PA , Tu T , Netter HJ , et al. The evolution and clinical impact of hepatitis B virus genome diversity[J]. Nat Rev Gastroenterol Hepatol, 2020, 17 (10): 618- 634.
17
Fernandes da Silva C , Keeshan A , Cooper C . Hepatitis B virus genotypes influence clinical outcomes: A review[J]. Can Liver J, 2023, 6 (3): 347- 352.
18
Likhitsup A , Lok AS . Understanding the natural history of hepatitis B virus infection and the new definitions of cure and the endpoints of clinical trials[J]. Clin Liver Dis, 2019, 23 (3): 401- 416.
[1] 高鹏,雒艳萍,李俊峰,陈琳,毛小荣. 乙型肝炎病毒在不同丙氨酸氨基转移酶状态下对Th17、Treg细胞及其比率的影响[J]. 北京大学学报(医学版), 2022, 54(2): 272-277.
[2] 高鹏,雒艳萍,李俊峰. B/C基因型的乙型肝炎病毒对不同免疫阶段慢性乙型肝炎患者T淋巴细胞及其亚群的影响[J]. 北京大学学报(医学版), 2020, 52(6): 1153-1156.
[3] 高凌, 李晓红, 赵建晴, 陆继红, 朱佳石, . MassARRAY单核苷酸多态性MALDI-TOF质谱基因分型法检测未成熟冬虫夏草子座中多个冬虫夏草菌突变基因型[J]. 北京大学学报(医学版), 2011, 43(2): 259-266.
[4] 唐迅, 朱燕萍, 李娜, 陈大方, 张宗欣, 窦会东, 胡永华. 北京市房山区缺血性脑卒中表型不一致同胞对的遗传流行病学研究[J]. 北京大学学报(医学版), 2007, 39(2): 119-125.
[5] 张瑞, 李俊强, 刘丽君, 杜绍财, 魏来. 丙型肝炎病毒6a型感染的状态与分析[J]. 北京大学学报(医学版), 2006, 38(6): 614-617.
[6] 尹洪芳, 李挺. 胃肠B细胞淋巴瘤中幽门螺杆菌的基因表型[J]. 北京大学学报(医学版), 2006, 38(2): 189-192.
[7] Weina JU, Anetta WRONSKA, Dorota N. MOROZIEWICZ. 神经元蜡样质脂褐质沉积病(NCL)的基因型与表型相关性研究[J]. 北京大学学报(医学版), 2006, 38(1): 41-48.
[8] 李东明, 李若瑜, 王晓红, 万喆, 马圣清, 王端礼. 甄氏外瓶霉的核糖体基因分型研究[J]. 北京大学学报(医学版), 2005, 37(2): 167-171.
[9] 吕筠, 詹思延, 秦颖, 李群娜, 郭晓霞, 曹卫华, 逄增昌, 薄涛, 胡永华, 李立明, 刘雅诚, 霍振义, 梁国栋. 流行病学研究中的双生子卵性鉴定[J]. 北京大学学报(医学版), 2003, 35(2): 212-214.
[10] 李东明, 李若瑜, 王端礼, 孔繁荣, 卜定方, 冀朝辉, 马圣清. 皮炎外瓶霉的核糖体基因研究[J]. 北京大学学报(医学版), 2002, 34(3): 266-270.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!